STING1 and neoplasm: The cGAS-STING pathway in tumor cells has been linked to the activation of the innate immune system, local activation of antigen-presenting cells, recruitment of effector lymphocytes, and sensitization of the tumor microenvironment to immune checkpoint inhibitor therapy [32].